Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG).

MLA

Henno, S., et al. “Potential Histological Discordance Revealed by Second Review in the National Rare Gynecological Cancer Network (TMRG).” Gynecologic Oncology, vol. 165, no. 3, June 2022, pp. 637–41. EBSCOhost, https://doi.org/10.1016/j.ygyno.2022.03.019.

APA

Henno, S., Jeanne, C., Rouge, T. D. L. M., Genestie, C., Treilleux, I., Croce, S., Just, P. A., Le Frere-Belda, M. A., Guinaudeau, E., Penault-Llorca, F., Arnould, L., Mery-Lamarche, E., Leroux, A., Lemaire, A. S., Averous, G., Renaud, O., Charafe-Jauffret, E., Bonneau, C., Leaha, C., & Ray-Coquard, I. (2022). Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG). Gynecologic Oncology, 165(3), 637–641. https://doi.org/10.1016/j.ygyno.2022.03.019

Chicago

Henno, S., C. Jeanne, T. De La Motte Rouge, C. Genestie, I. Treilleux, S. Croce, P.A. Just, et al. 2022. “Potential Histological Discordance Revealed by Second Review in the National Rare Gynecological Cancer Network (TMRG).” Gynecologic Oncology 165 (3): 637–41. doi:10.1016/j.ygyno.2022.03.019.